Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes : a randomised crossover study. / Steineck, Isabelle I. K.; Ranjan, Ajenthen; Schmidt, Signe; Clausen, Trine R.; Holst, Jens Juul; Norgaard, Kirsten.

In: Diabetologia, Vol. 62, No. 4, 2019, p. 582-592.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Steineck, IIK, Ranjan, A, Schmidt, S, Clausen, TR, Holst, JJ & Norgaard, K 2019, 'Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study', Diabetologia, vol. 62, no. 4, pp. 582-592. https://doi.org/10.1007/s00125-018-4807-8

APA

Steineck, I. I. K., Ranjan, A., Schmidt, S., Clausen, T. R., Holst, J. J., & Norgaard, K. (2019). Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study. Diabetologia, 62(4), 582-592. https://doi.org/10.1007/s00125-018-4807-8

Vancouver

Steineck IIK, Ranjan A, Schmidt S, Clausen TR, Holst JJ, Norgaard K. Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study. Diabetologia. 2019;62(4):582-592. https://doi.org/10.1007/s00125-018-4807-8

Author

Steineck, Isabelle I. K. ; Ranjan, Ajenthen ; Schmidt, Signe ; Clausen, Trine R. ; Holst, Jens Juul ; Norgaard, Kirsten. / Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes : a randomised crossover study. In: Diabetologia. 2019 ; Vol. 62, No. 4. pp. 582-592.

Bibtex

@article{d645b076dbd347fb839f8af41f1ea672,
title = "Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes: a randomised crossover study",
abstract = "Aims/hypothesisThis study aimed to compare the increase in plasma glucose after a subcutaneous injection of 200g glucagon given after 45min of cycling with resting (study 1) and to investigate the effects of glucagon when injected before compared with after 45min of cycling (study 2). We hypothesised that: (1) the glucose response to glucagon would be similar after cycling and resting; and (2) giving glucagon before the activity would prevent the exercise-induced fall in blood glucose during exercise and for 2h afterwards.MethodsFourteen insulin-pump-treated individuals with type 1 diabetes completed three visits in a randomised, placebo-controlled, participant-blinded crossover study. They were allocated by sealed envelopes. Baseline values were (mean and range): HbA(1c) 54mmol/mol (43-65mmol/mol) or 7.1% (6.1-8.1%); age 45years (23-66years); BMI 26kg/m(2) (21-30kg/m(2)); and diabetes duration 26years (8-51years). At each visit, participants consumed a standardised breakfast 2h prior to 45min of cycling or resting. A subcutaneous injection of 200g glucagon was given before or after cycling or after resting. The glucose response to glucagon was compared after cycling vs resting (study 1) and before vs after cycling (study 2).ResultsThe glucose response to glucagon was higher after cycling compared with after resting (mean SD incremental peak: 2.61.7 vs 1.82.0mmol/l, p=0.02). As expected, plasma glucose decreased during cycling (-3.1 +/- 2.8mmol/l) but less so when glucagon was given before cycling (-0.9 +/- 2.8mmol/l, p=0.002). The number of individuals reaching glucose values 3.9mmol/l was the same on the 3days.Conclusions/interpretationModerate cycling for 45min did not impair the glucose response to glucagon compared with the glucose response after resting. The glucose fall during cycling was diminished by a pre-exercise injection of 200g glucagon; however, no significant difference was seen in the number of events of hypoglycaemia.Trial registrationThe study was funded by the Danish Diabetes Academy founded by Novo Nordisk foundation and by an unrestricted grant from Zealand Pharma",
keywords = "Exercise, Glucagon, Insulin pump-treated, Type 1 diabetes",
author = "Steineck, {Isabelle I. K.} and Ajenthen Ranjan and Signe Schmidt and Clausen, {Trine R.} and Holst, {Jens Juul} and Kirsten Norgaard",
year = "2019",
doi = "10.1007/s00125-018-4807-8",
language = "English",
volume = "62",
pages = "582--592",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "4",

}

RIS

TY - JOUR

T1 - Preserved glucose response to low-dose glucagon after exercise in insulin-pump-treated individuals with type 1 diabetes

T2 - a randomised crossover study

AU - Steineck, Isabelle I. K.

AU - Ranjan, Ajenthen

AU - Schmidt, Signe

AU - Clausen, Trine R.

AU - Holst, Jens Juul

AU - Norgaard, Kirsten

PY - 2019

Y1 - 2019

N2 - Aims/hypothesisThis study aimed to compare the increase in plasma glucose after a subcutaneous injection of 200g glucagon given after 45min of cycling with resting (study 1) and to investigate the effects of glucagon when injected before compared with after 45min of cycling (study 2). We hypothesised that: (1) the glucose response to glucagon would be similar after cycling and resting; and (2) giving glucagon before the activity would prevent the exercise-induced fall in blood glucose during exercise and for 2h afterwards.MethodsFourteen insulin-pump-treated individuals with type 1 diabetes completed three visits in a randomised, placebo-controlled, participant-blinded crossover study. They were allocated by sealed envelopes. Baseline values were (mean and range): HbA(1c) 54mmol/mol (43-65mmol/mol) or 7.1% (6.1-8.1%); age 45years (23-66years); BMI 26kg/m(2) (21-30kg/m(2)); and diabetes duration 26years (8-51years). At each visit, participants consumed a standardised breakfast 2h prior to 45min of cycling or resting. A subcutaneous injection of 200g glucagon was given before or after cycling or after resting. The glucose response to glucagon was compared after cycling vs resting (study 1) and before vs after cycling (study 2).ResultsThe glucose response to glucagon was higher after cycling compared with after resting (mean SD incremental peak: 2.61.7 vs 1.82.0mmol/l, p=0.02). As expected, plasma glucose decreased during cycling (-3.1 +/- 2.8mmol/l) but less so when glucagon was given before cycling (-0.9 +/- 2.8mmol/l, p=0.002). The number of individuals reaching glucose values 3.9mmol/l was the same on the 3days.Conclusions/interpretationModerate cycling for 45min did not impair the glucose response to glucagon compared with the glucose response after resting. The glucose fall during cycling was diminished by a pre-exercise injection of 200g glucagon; however, no significant difference was seen in the number of events of hypoglycaemia.Trial registrationThe study was funded by the Danish Diabetes Academy founded by Novo Nordisk foundation and by an unrestricted grant from Zealand Pharma

AB - Aims/hypothesisThis study aimed to compare the increase in plasma glucose after a subcutaneous injection of 200g glucagon given after 45min of cycling with resting (study 1) and to investigate the effects of glucagon when injected before compared with after 45min of cycling (study 2). We hypothesised that: (1) the glucose response to glucagon would be similar after cycling and resting; and (2) giving glucagon before the activity would prevent the exercise-induced fall in blood glucose during exercise and for 2h afterwards.MethodsFourteen insulin-pump-treated individuals with type 1 diabetes completed three visits in a randomised, placebo-controlled, participant-blinded crossover study. They were allocated by sealed envelopes. Baseline values were (mean and range): HbA(1c) 54mmol/mol (43-65mmol/mol) or 7.1% (6.1-8.1%); age 45years (23-66years); BMI 26kg/m(2) (21-30kg/m(2)); and diabetes duration 26years (8-51years). At each visit, participants consumed a standardised breakfast 2h prior to 45min of cycling or resting. A subcutaneous injection of 200g glucagon was given before or after cycling or after resting. The glucose response to glucagon was compared after cycling vs resting (study 1) and before vs after cycling (study 2).ResultsThe glucose response to glucagon was higher after cycling compared with after resting (mean SD incremental peak: 2.61.7 vs 1.82.0mmol/l, p=0.02). As expected, plasma glucose decreased during cycling (-3.1 +/- 2.8mmol/l) but less so when glucagon was given before cycling (-0.9 +/- 2.8mmol/l, p=0.002). The number of individuals reaching glucose values 3.9mmol/l was the same on the 3days.Conclusions/interpretationModerate cycling for 45min did not impair the glucose response to glucagon compared with the glucose response after resting. The glucose fall during cycling was diminished by a pre-exercise injection of 200g glucagon; however, no significant difference was seen in the number of events of hypoglycaemia.Trial registrationThe study was funded by the Danish Diabetes Academy founded by Novo Nordisk foundation and by an unrestricted grant from Zealand Pharma

KW - Exercise

KW - Glucagon

KW - Insulin pump-treated

KW - Type 1 diabetes

U2 - 10.1007/s00125-018-4807-8

DO - 10.1007/s00125-018-4807-8

M3 - Journal article

C2 - 30643924

VL - 62

SP - 582

EP - 592

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 4

ER -

ID: 229147231